Evidence map›Paper›PMID 24842641›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2014

IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.

O Traitanon, A Gorbachev, J J Bechtel, K S Keslar, W M Baldwin, E D Poggio, R L Fairchild

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Exhaustion-Resistant CD8Immunology · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Endogenous memory T cells with donor-reactivity: early post-transplant mediators of acute graft injury in unsensitized recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Human CD8Frontiers in immunology · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Increased Pretransplant Frequency of CD28American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2017
    Article
  18. Immune and myodegenerative pathomechanisms in inclusion body myositis.Annals of clinical and translational neurology · 2017
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

O TraitanonDepartment of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH; Division of Nephrology, Department of Internal Medicine, Thammasart University, Pathumthani, Thailand.
A Gorbachev
J J Bechtel
K S Keslar
W M Baldwin
E D Poggio
R L Fairchild
Cleveland Clinic · USCleveland Clinic Lerner College of Medicine · USCase Western Reserve University · USUniversity School · US

Funding

POSTTRANSPLANT INFLAMMATORY RESPONSER01AI040459 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI Robert L Fairchild · 1997 to 2026
$9.4M
Alloreactive T Cell Immunity in Human Transplant CandidatesK23AI068824 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI POGGIO, EMILIO DANIEL · 2007 to 2011
$540k
NIAID NIH HHS K23 AI068824NIAID NIH HHS K23-AI68824NIAID NIH HHS R01 AI040459NIAID NIH HHS R01-AI40459
6 · The paper itself

Abstract

The presence of CD28(-) memory CD8 T cells in the peripheral blood of renal transplant patients is a risk factor for graft rejection and resistance to CTLA-4Ig induction therapy. In vitro analyses have indicated poor alloantigen-induced CD28(-) memory CD8 T cell proliferation, raising questions about mechanisms mediating their clonal expansion in kidney grafts to mediate injury. Candidate proliferative cytokines were tested for synergy with alloantigen in stimulating CD28(-) memory CD8 T cell proliferation. Addition of IL-15, but not IL-2 or IL-7, to co-cultures of CD28(-) or CD28(+) memory CD8 T cells and allogeneic B cells rescued proliferation of the CD28(-) and enhanced CD28(+) memory T cell proliferation. Proliferating CD28(-) memory CD8 T cells produced high amounts of interferon gamma and tumor necrosis factor alpha and expressed higher levels of the cytolytic marker CD107a than CD28(+) memory CD8 T cells. CTLA-4Ig inhibited alloantigen-induced proliferation of CD28(+) memory CD8 T cell proliferation but had no effect on alloantigen plus IL-15-induced proliferation of either CD28(-) or CD28(+) memory CD8 T cells. These results indicate the ability of IL-15, a cytokine produced by renal epithelial during inflammation, to provoke CD28(-) memory CD8 T cell proliferation and to confer memory CD8 T cell resistance to CTLA-4Ig-mediated costimulation blockade.

Indexed as

Immunologic MemoryLymphocyte ActivationCD28 AntigensCD8-Positive T-LymphocytesCTLA-4 AntigenHumansInterleukin-15Lymphocyte Culture Test, MixedCD28 AntigensCTLA-4 AntigenInterleukin-15belataceptCostimulationcytokines/cytokine receptorsimmunosuppressantT cell biology

Identifiers

PMID24842641
PMCPMC6083870
OpenAlexW1571148007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.